id,drug1,object,drug2,precipitant,certainty,contraindication,dateAdded,ddiPkEffect,ddiPkMechanism,effectConcept,homepage,label,numericVal,objectUri,pathway,precaution,precipUri,severity,uri,whoAnnotated,source,ddiType,evidence,evidenceSource,evidenceStatement,researchStatementLabel,researchStatement,managementOptions
190,http://bio2rdf.org/drugbank:DB00641,simvastatin,http://bio2rdf.org/drugbank:DB01167,itraconazole,None,None,None,None,None,None,None,"itraconazole is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4",None,None,http://purl.obolibrary.org/obo/PR_000006130,None,None,None,http://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/376,None,DIKB,DDIPrediction,None,None,None,None,None,None
11490,http://bio2rdf.org/drugbank:DB00641,Simvastatin,http://bio2rdf.org/drugbank:DB01167,Itraconazole,None,None,None,None,None,None,None,"Increased risk of myopathy/rhabdomyolysis|",None,None,None,None,None,None,None,None,Drugbank,None,None,None,None,None,None,None
43751,http://bio2rdf.org/drugbank:DB00641,Simvastatin,http://bio2rdf.org/drugbank:DB01167,Itraconazole,None,True,None,None,None,None,None,None,None,None,None,None,None,None,http://rest.kegg.jp/ddi/D00434,None,Kegg,None,None,None,None,None,None,None
78824,http://bio2rdf.org/drugbank:DB00641,SIMVASTATIN,http://bio2rdf.org/drugbank:DB01167,ITRACONAZOLE,None,None,None,None,"Inhibition of simvastatin/ lovastatin metabolism by CYP3A4","Increased simvastatin/ lovastatin concentrations and risk of myopathy/ rhabdomyolysis",None,None,None,None,None,None,None,None,None,None,CredibleMeds,None,None,None,None,None,None,"Usually Avoid 路Consider Alternative Antifungal Agents: Terbinafine or ciclopirox nail lacquer would be relatively safer antifungal agents. 路Consider Alternative Statins: For patients requiring long-term azole antifungal therapy, preferable statin alternatives include fluvastatin, rosuvastatin, or pravastatin. 路Temporarily Hold Statin Therapy: Temporarily holding the simvastatin/lovastatin during short-term (e.g., 2-week) azole antifungal therapy is a reasonable alternative for patients with stable cardiovascular disease. 路Monitor: If alternatives are not appropriate, the patient should be monitored for evidence of myopathy (muscle pain or weakness) and myoglobinuria (dark urine)."
82988,http://bio2rdf.org/drugbank:DB00641,Simvastatin,http://bio2rdf.org/drugbank:DB01167,Itraconazole,None,None,None,None,None,None,None,None,None,None,None,None,None,None,None,None,ONC-HighPriority,None,None,None,None,None,None,None
